Sunshine Biopharma earnings beat by $0.05, revenue topped estimates
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
Kenanga maintains ringgit forecast of RM3.95 to US dollar by year-end
KUALA LUMPUR: Kenanga Investment Bank Bhd (Kenanga IB) has retained its ringgit forecast of RM3.95 to the US dollar by year-end, underpinned by resilient growth, a sustained current account (CA)…
Indian Shares Open Lower As Hormuz Tensions Rise
(RTTNews) - Indian shares opened lower on Monday amid lingering uncertainty surrounding U.S.-Iran peace talks and the Strait of Hormuz.
Indian Rupee holds ground despite RBI ending FCNR forex swap window early
The Indian Rupee (INR) trades stronger against the US Dollar (USD) on Monday after two days of losses, with the USD/INR pair trading around 95.50 at the time of writing.
Sembcorp Said to Plan Filing for $500 Million IPO of India Unit
Singapore-based Sembcorp Industries Ltd. is preparing to file for an initial public offering of its Indian unit, Sembcorp Green Infra Ltd., that could raise as much as $500 million, according to…
Rupee falls 17 paise to 95.59 against US dollar in early trade
Investors cautious after RBI shortens swap window for FCNR (B) deposits, say forex traders